Home › Funds › Catalio Capital Management, LP › GPCR

Catalio Capital Management, LP position in GPCR

STRUCTURE THERAPEUTICS INC · Health Care

Catalio Capital Management, LP reported holding 276,550 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$14.8M, representing 2.79% of its reported portfolio and ranking #15 among its reported holdings. Catalio Capital Management, LP has disclosed GPCR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)276.55K sh
Reported value held$14.84M
Portfolio Weight2.79%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's GPCR position evolved

Catalio Capital Management, LP first disclosed a stake in GPCR in Q4 2024 at 569,395 shares (US$15.4M). The position peaked in Q3 2025 at 651,810 shares, worth US$18.3M. Across 7 filings, Catalio Capital Management, LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 276,550 shares valued at US$14.8M — an increase of 21,171 shares quarter over quarter.. Notable position changes include a 61% trim in Q4 2025 (shares fell 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 569.39K $15.44M New
Q1 2025 704.86K $12.20M Add
Q2 2025 670.58K $13.91M Reduce
Q3 2025 651.81K $18.25M Reduce
Q4 2025 252.90K $17.59M Reduce
Q1 2026 255.38K $12.31M Add
Q2 2026 276.55K $14.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GPCR and 13F data

GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GPCR

All GPCR fund holders →

FAQ

How long has Catalio Capital Management, LP held GPCR?

Catalio Capital Management, LP has disclosed GPCR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Catalio Capital Management, LP's current position in GPCR?

As of Q2 2026, Catalio Capital Management, LP holds 276.55K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $14.84M, representing 2.79% of its reported portfolio and ranking #15.

Has Catalio Capital Management, LP been buying or selling GPCR?

In the latest 13F filing (Q2 2026), Catalio Capital Management, LP increased its position in GPCR. The position peaked in Q3 2025 at 651.81K shares.

Which other funds hold GPCR?

Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.